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Antimicrobial activityAbstract A bioassay-directed fractionation of n-hexane and chloroform extracts of the tuberous
roots of Neorautanenia mitis resulted in the isolation of a new isoﬂavonoid, named neoraudiol
(1) and ﬁve known compounds: rautandiol A (2), neoduline (3), neotenone (4), pachyrrhizine (5)
and 12a-hydroxylrotenone (6). The structure of the new compound was established on the basis
of spectroscopic studies and comparison with known compounds. Isolated compounds exhibited
broad spectrum antimicrobial activity ranging from 15 to 80 mg/ml, the most signiﬁcant activity
(MIC15.10 ± 0.5 mg/ml) was exhibited by neoraudiol. Structure–activity relationship is described.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Neorautanenia mitis (A. Rich) Verdcourt (Fabaceae) is a legu-
minous subshrubby plant found growing in rocky soil. N. mitis
is native to the Central, South and West Africa and one of the
10 species of Neorautanenia (Burkill, 1995). Previously re-
ported constituents of N. mitis include isoﬂavones, coumarin
derivatives and pterocarpans (Cromble and Whiting, 1962;
Luc et al., 1987; Joseph et al., 2004; Yojiro et al., 2006). The
root decoction of N. mitis is reported in traditional medicine
as ﬁsh poison and for killing bilharzias-carrying fresh water
snails; powdered root of N. mitis is reputed for its insecticidaland insect-repellant properties, treatment of syphilis, female
frigidity and skin infections like scabies and rashes (Luc et
al., 1987; Heydoricks et al., 1992; Leticia et al., 2008). The root
petroleum extracts of N. mitis have signiﬁcant acaricidal activ-
ity against female ticks, larvacidal and mosquitocidal activities
against larvae of Anopheles gambiae and Culex quinquefaciatus
mosquitoes (Luc et al., 1987; Joseph et al., 2004). Cytotoxic
activities of the EtOAc extract of N. mitis in human MCF-7
breast and A-549 lung cancer have been reported (Yojiro
et al., 2006). Aqueous extract of N. mitis is reported to have
dose-dependent anti-ioceptic activity at 12.5 and 50.0 mg/ml
p.o. in mice and slight inﬂammatory activity at 25 and
50 mg/ml p.o. (Vongtau et al., 2005). Neotenone, pachyrrhi-
zine, neorautanone, neoduline, nepseudin, 12a-hydroxyl
rotenone, rautandiol A and B are implicated for these activi-
ties. However, a study on the antimicrobial activity of constit-
uents from N. mitis is rare in the literature. Flavonoids and
pterocarpans are reported as important phytoalexins (Cecile
et al., 2003; Leticia et al., 2008). In this context, our continuing
interest in antimicrobial agents of potential medicinal use led
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medical practice in Nigeria for the treatment of scabies and
rashes. Herein, the isolation and structural elucidation of a
new isoﬂavonoid, neoraudiol (1), along with ﬁve known com-
pounds [rautandiol A (2), neoduline (3), pachyrrhizine (4),
neotenone (5) and 12a-hdroxyrotenone (6)] from the tuberous
roots of N. mitis are described. The chemical structures of
compound 1 were established by detailed 1D and 2D NMR,
EIMS, UV, IR spectroscopic data, and comparison of those
data with published values. Compounds 1–6 were evaluated
in vitro for their growth inhibition on three Gram-negative
bacteria [(Eschericia coli, ATCC 1053, Pseudomonas auerigin-
osa, ATCC 278660), Salmonella typhii (Lab. Stock)], two
Gram-positive bacterial strains (Bacillus substilis, ATCC
6052, Staphylococcus aureus, ATCC 13705) and two fungi:
Candida albicans and Aspergillus niger.
2. Materials and methods
2.1. General procedures
Melting points (mp) uncorrected were determined with the aid
of Gallenkamp (Phillip Harris, England) melting apparatus.
Analytical and preparative chromatographic procedures
utilised adsorption chromatography. Analytical thin layer
Chromatography (TLC) was performed using commercial
pre-coated plates (Kieselgel, 60PF254, 0.25 mm thick on poly-
ester backing (Merck, Damstadt, Germany), spots were visual-
ised in iodine vapour. Column chromatography was
performed on open column silica gel (Merck, 60, 70–230
mesh). IR spectra were recorded on Unican FT-IR 2000 model
spectrophotometer, in Nujol and KBr pellets. UV spectrum
was recorded on a Unikon model 930 and Lambda 3B model
spectrophotometers. EIMS (70 eV) and GC–MS were acquired
using JEOL MS Revile (Direct probe). 1H- and 13C-NMR
spectra were acquired on a Bruker WP 120054 (400 MHz,
500 MHz for 1H- and 100 MHz for 13C-NMR) spectrometer
with TMS as internal reference in CDCl3 and CD3OD. Chem-
ical shift values are expressed in ppm and coupling constant (J)
in Hertz (Hz). Gentamicin was used as reference antimicrobial
drugs while thioconazole served as reference antifungal drug.
2.2. Plant material
The tuberous roots of N. mitis were collected from the rocky
soil along Suleja-Abuja road, Niger State, Nigeria, in June
2007. The plant was botanically identiﬁed by Mr. O.A. Ohaeri
of the National Institute for Pharmaceutical Research and
Development (NIPRD), Idu Abuja, Nigeria. Voucher speci-
men was deposited in the herbarium of NIPRD with accession
number NIPRD 11225.
2.3. Extraction and isolation
Dried and powdered tuberous roots of N. mitis (1.5 kg) were
exhaustively and successively extracted by percolation with
n-hexane and CHCl3 (72 h each, reﬂux). The extract was con-
centrated to yield 28 g hexane and 35 g CHCl3 extracts.
The CHCl3 extracts of N. mitis (6 g) were chromatographed
on silica gel packed column, eluent: n-hexane–Et2O gradient,
100 ml. Fractions (Frs.) 1–42 (n-hexane), 43–69 (hexane–
Et2O, 9:1), 70–96 (hexane–Et2O, 8:2), 97–143 (hexane–Et2O,7:3), 144–166, (hexane–Et2O, 2:3) and 167–186 (Et2O). Identi-
cal fractions were grouped into six subfractions on the basis of
TLC. Frs 1–42 (A), 43–69 (B), 72–110 (C), 111–143 (D), 144–
169 (E) and167–186 (F). Fr. E (100 mg) was rechromato-
graphed on a silica gel narrow column (hexane–Et2O stepwise
gradient, 50 ml), eluting progressively with 100% n-hexane up
to 50% hexane–Et2O, yielding neoraudiol (1) and rautandiol
(2).
The n-hexane extract of N. mitis (5 g) was chromato-
graphed on a silica gel packed column, eluting with hexane–
Et2O stepwise gradient. Fractions obtained were bulked into
four (A–D) on the basis of TLC. Subfractions A and C yielded
compounds 3 and 4. Fraction D (400 mg) was rechromato-
graphed in a silica gel narrow column, eluted gradually in hex-
ane–Et2O gradient. Subfractions 25–35, eluted with 70%
hexane in Et2O afforded yellow solid, pachyrrhizine (65 mg,
5). The subfractions 45–64 eluted with 60% hexane in Et2O
afforded yellow powder, 12a-hydroxy rotenone (500 mg, 6)
after recrystallisation in hexane–EtOAc (8:1, vol/vol).
2.3.1. Compound 1 (neoraudiol)
Compound 1 was eluted with 75% hexane–Et2O and isolated
as light-green powder (65 mg), after recrystallisation in hex-
ane–EtOAc (3:1, vol/vol), mp 205–206 C; 1R (tmax, cm1,
KBr): 3781.2, 1665.7, 1593.8, 1475.2 and 1162.3. UV [(kmax,
nm) (emax)]: 389.8 (0.04), 323 (0.12) and 233.8 (0.89);
1H-
NMR (CD3OD, 400 MHz) d (ppm): 8.49 (1H, s, H-5), 8.25
(1H, s, H-2), 7.94 (1H, d, J= 2 Hz H-200), 7.76 (1H, s, H-8),
7.10 (1H, d, J= 8 Hz H-50), 7.05 (1H, dd, J= 2, 1.6 Hz H-
300), 6.41 (1H, dd, J= 8, 2.0 Hz H-60), 6.38 (1H, d, J= 2 Hz
H-20); 13C-NMR (100 MHz, CD3OD) d (ppm): 180 (C-4),
160 (C-8a), 159 (C-7), 157.4 (C-2), 149.7 (C-200), 133.1 (C-20),
123.5 (C-3), 122 (C-10), 120 (C-5), 119.4 (C-4a), 119 (C-6),
108.3 (C-60), 107.9 (C-40), 106.1 (C-300), 104.5 (C-50), 104.1
(C-30), and 100.9 (C-8). E1MS [(m/z (rel. int. (%)]: 293.6
[(M+), 13.34)], 276.7 (11.1), 264.7 (2.4), 236.7 (3.3), 160.8
(100), 146.9 (12.1), 133.9 (33.9), 119.9 (11.3), 104.9 (21.1),
90.9 (44.4), 76.9 (25.8), 65.0 (13.5), 50.0 (13.7).
2.3.2. Compound 2 (rautandiol)
Compound 2 was eluted with 50% hexane–Et2O and isolated
as grey powder (83 mg), upon recrystallisation in hexane–
EtOAc (1:1, vol/vol), mp 210–211 C (lit mp 210–211 C);
1H-NMR (CD3OD, 400 MHz) d (ppm): 7.17 (1H, s, H-1),
7.06 (1H, d, J= 8 Hz, H-7), 6.31(1H, dd, J= 8, 3H, s, H-
40), 6.26 (1H, s, H-4), 4.18 (1H, dd, J= 9.6, 3.1 Hz, H-6eq),
3.51(1H, dd, J = 10.5, 9.6 Hz H-6ax), 3.50–3.46 (1H, m, H-
6a), 1.24 (3H, s, H-50); 13C-NMR (CD3OD, 100 MHz), d
(ppm): 162.1(C-10a), 159.9 (C-9), 156.6 (C-4a), 155.7 (C-3),
133.3 (C-1), 126.1 (C-7), 119.6 (C-7a), 115.5 (C-2), 114.5 (C-
1a), 108.8 (C-8), 105.4 (C-4), 98.9 (C-10), 80.01 (C-11a), 78.6
(C-30), 70.72 (C-20), 68.3 (C-6a), 41.2 (C-6), 31.7 (C-11), 26.1
(C-40), and 21.1 (C-50); E1MS (m/z (rel. int., %): 340.9
[(M+ H)+, 29.1)], 339.9 (94.5), 338.9 (13.3), 320.9 (2.5),
306.8 (6.8), 268.9 (100), 140.9 (5.2), 198.9 (9.3), 170.9 (4.9),
152.9 (4.1), 138.9 (3.2), 91.0 (9.6), 68.9 (40.7).
2.3.3. Compound 3 (neoduline)
Compound 3 was eluted with 90% hexane–Et2O and isolated
as white powder (95 mg), mp 216–217 C (lit mp 217 C);
1H-NMR: (400 MHz, CDCl3), d (ppm): 7.76 (1H, s, H-1),
7.57 (1H, d, J= 2.5 Hz, H-200), 7.10 (1H, s, H-4), 6.76 (1H,
Table 1 1H-NMR spectroscopic data of compound 1.
Positions dH HMBC NOESY
2 8.25 s C-4, 4a, 6, 8
5 8.49 s C-2, 4, 6, 7, 10
8 7.76 s C-2, 200, 6 H-20
20 6.38 d (2) C-3, 40, 50, 60 H-50
50 7.10 d (8) C-3,10, 20, 30, H-20
60 6.41 dd (8, 2) C-3, 20, 30 H-50
200 7.94 d (2) C-6, 8, 8a H-300
300 7.05 dd (2, 1.6) C-4, 4a H-200
–OH 4.81 s, br H-50, 60
1H-NMR, HMBC and NOESY spectral data were acquired in
CD3OD at 400 MHz. Chemical shift values are shown in the d scale
(ppm), with coupling constants (J, Hz) in parentheses, s = singlet,
d = doublet, dd = doublet of doublet.
406 A.A. Lasisi, A. Adesomojus, H-7), 6.45 (1H, s, H-10), 6.73 (1H, dd, J= 2.5, 1 Hz H-300),
5.94 (1H, d, J= 1.5 Hz) H-4), 5.91 (1H, d, J= 1.5 Hz, H-2000),
5.68 (1H, d, J = 7 Hz), 4.29 (1H, dd, J= 11, 5 Hz, H-6eq),
3.78 (1H, dd, J= 11, 11 Hz, H-6ax), 3.60 (1H, ddd, J= 11,
7, 5 Hz, H-6a); 13C-NMR (100 MHz, CDCl3) d (ppm): 155.7
(C-3), 154.3 (C-10a), 153.5 (C-4a), 145.1 (C-20), 122.9 (C-1),
122.4 (C-2), 117.9 (C-7a), 116.7 (C-1a), 106.3 (C-300), 101.3
(C-2000), 99.9 (C-4), 93.9 (C-10), 79.3 (C-11a) and 40.6 (C-6a);
EIMS: m/z [rel. int. (%)]: 307.6 (M+, 88.3), 306.7 (13.2),
293.7 (20.1), 278.7 (6.6), 264.9 (2.6), 220.8 (3.8), 184.9 (5.5),
170.8 (10.4), 57.1 (100), 152.8 (3.3), 138.8 (3.9), 120.98 (3.1),
106.96 (6.4), 90.9 (59.1), 76.9 (12.7).
2.3.4. Compound 4 (neotenone)
Compound 4 was eluted with 80% hexane–Et2O as greenish-
white solid (100 mg), after recrystallisation in hexane–EtOAc
(3:1), mp 157–158 C (lit mp 156 C); 1H-NMR [(CDCl3),
500 MHz), d (ppm)]: 8.37 (1H, s, H-5), 7.59 (1H, d
J= 2 Hz, H-200), 7.08 (1H, s, H-8), 6.78 (1H, dd J = 2, 1 Hz
H-300), 6.63 (1H, s, H-60), 6.58 (1H, s, H-30), 5.92 (1H, s, H-
2000), 4.59 (1H, dd J= 11.2, 11.6 Hz H-2), 4.51 (1H, dd
J= 11.2, 5.6 Hz, H-2), 4.31(1H, dd J= 11.6, 5.6) and 3.71
(3H, s, OCH3);
13C-NMR [(100 MHz, CDCl3), d (ppm)]:
193.0 (C-4), 159.9 (C-8a), 159.6 (C-7), 153.1 (C-20), 148.0 (C-
40), 146.0 (C-200), 141.7 (C-50), 123.0 (C-10), 121.0 (C-5), 118.8
(C-4a), 115.8 (C-6), 109.0 (C-60), 107.0 (C-300), 101.3 (C-2000),
99.8 (C-8), 95.5 (C-30), 71.5 (C-2), 56.5 (–OCH3) and 48.0
(C-3).
2.3.5. Compound 5 (pachrrhizine)
Compound 5 was eluted from column with 7:3 hexane–Et2O
and recrystallised from hexane/EtOAc solvent mixture (7:3,
vol/vol) to afford a yellow solid [65 mg ], mp 206–207 C (lit
mp 204–205 C); 1H-NMR [(CDCl3, 400 MHz,), d (ppm)]:
7.79 (1H, s, H-4), 7.68 (1H, s, H-5), 7.67(1H, d, J= 2 Hz H-
200), 7.49 (1H, s, H-8), 6.89 (1H, s, H-60), 6.82 (1H, dd J= 2,
1 Hz), 6.63 (1H, s, H-30), 5.96 (1H, s, H-2000) and 3.77 (3H, s,
br-OCH3); MS: 336 (M
+, 100%), 321, 305, 293, 265, 249.
2.3.6. Compound 6 (12a-hydroxy rotenone)
Compound 6 was eluted from column with 3:2 hexane–Et2O as
a yellow solid (500 mg, mp 86–87 C (lit mp 87–88 C); 1H-
NMR (CDCl3, 400 MHz) d (ppm): 7.81 (1H, d, J= 8.6 Hz
H-110), 6.73 (1H, d, J= 8.6 Hz, H-10), 6.56 (1H, s, H-1),
6.49 (1H, s, H-4), 5.27 (1H, m, H- 50), 4.59 (2H, m, H-6),
4.6–5.1 (2H, m, br H-70), 4.55 (2H, m, H-6a), 3.83 (3H, s,
OCH3), 3.73 (3H, s, OCH3), 3.1–3.2 (2H, m, H-4
00) and 1.73
(3H, s, H-80); 13C-NMR (400 MHz,), d (ppm): 191.1 (C-12),
168 (C-9), 157.7 (C-7a), 151.1 (C-3), 148.4 (C-4a), 142.9 (C-
60), 142.7 (C-2), 130.1 (C-11), 118.8 (C-11a), 113.9 (C-8),
112.7 (C-70), 109.4 (C-1a), 108.8 (C-1), 105.3 (C-10), 101.1(C-
4), 88 (C-50), 76.1 (C-6a), 67.6 (C-12a), 63.8 (C-6), 55.9, 56.4
(OCH3), 31.1(C-4
00) and 17.1 (C-80); MS: m/z (rel int., %):
410 (M+, 1.5%), 392 (0.3%), 208 (100%), 193 1.1%), 181
(0.6%), 165 (1.0%).
2.4. Minimum inhibitory concentration (MIC)
The MIC values of compounds 1–6 were determined using a
reported procedure with slight modiﬁcation (Ieven et al.,1979). Varying concentrations (200, 150, 100, 50, 25 and
12.5 mg/ml) of samples were prepared. 0.1 ml of each sample
was added to 9 ml nutrient broth containing 0.1 ml of stand-
ardised test organism (bacterial cells). The tubes were incu-
bated at 37 C for 24 h. Positive controls were set up by
using DMSO. Ten milligrams per millilitre of the isolated com-
pounds 1–6 were assayed as described above. The tube with the
least concentration of extract without growth after incubation
was taken and recorded as the minimum inhibitory concentra-
tion (MIC). Minimum fungicidal concentration (MFC) values
were recorded as the concentrations of the lowest clear wells of
each extract. The assay was carried out in duplicate.
2.5. Statistical analysis
All data were expressed as the mean ± S.E.M., data were sub-
jected to two-way ANOVA followed by Student’s t-test, using
Microsoft Excel* and Statistical* computer software packages.
Difference in mean was considered signiﬁcant when P 6 0.05.
3. Results and discussion
3.1. Compound 1 (neoraudiol)
Compound 1 was eluted from column with hexane/Et2O (3:1,
vol/vol) and recrystallised from hexane–EtOAc (3:1, vol/vol)
as light-green powder (65 mg), mp 205–206 C. It gave a posi-
tive ferric chloride reaction, indicative of its phenolic nature.
Its EIMS spectrum gave a molecular ion peak at m/z 294, cor-
responding to the molecular formula C17H10O5. Infra red
absorption bands at 3781.2, 1665.7, 1593.8 cm1 indicated
the presence of hydroxyl, conjugated carbonyl and arene
C‚C functional groups, respectively. The UV spectrum of 1
displayed two maximum bands [kmax (EtOH)] at 389.8 and
323 nm, characteristic of a,b-unsaturated ketones (Chun-Ru
et al., 2010). The 1H-NMR spectrum of 1 (Table 1) gave reso-
nances of 8 aromatic protons at d 8.49 [1H, s, H-5], d 8.25 [1H,
s, H-2], d 7.94 [1H, d, J= 2 Hz H-200], d 7.76 [1 H, s, H-8], d
7.10 [1H, d, J= 8 Hz, H-50], d 7.05 [1H, dd, J= 2, 1.6 Hz
H-300], d 6.41 [1H, dd, J= 8, 2 Hz H-60] and d 6.38 [1H, d,
J= 2 Hz, H-20]. The two proton signals at d 7.05 [1H, dd,
J= 2, 1.6 Hz, H-300] and d 7.94 [1H, d, J= 2 Hz H-200] were
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Figure 1 Fragmentation pattern of 1.
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an analysis of its NOESY 2D NMR data. The COSY spectrum
of 1 indicated two isolated spin system for H-50/H-60 and H-200/
H-300. The 13C-NMR and DEPT spectra of 1 exhibited eightmethine and nine quaternary carbons, including a carbonyl
carbon at d 180 ppm [C-4]. The 8 methine carbons resonates
at d 157.4 [C-2], d 149.7 [C-200], d 133.1 [C-20], d 120 [C-5], d
108.3 [C-60], d 106.1 [C-300], d 104.5 [C-50], and d 100.9 [C-8].
Table 2 Minimum inhibitory concentration of compounds isolated from N. mitis.
Compounds Micro-organisms/MIC (mg/ml) values
S. A. B. S. E. C. P. A. S. T. C. A. A. N.
Neoduline NA NA 75.1 ± 0.2 NA 66.3 ± 1.9 11.5 ± 0.1 11.2 ± 0.4
Neotenone 55.1 ± 0.8 45.2 ± 0.3 NA NA NA 11.2 ± 0.2 22.2 ± 0.1
Pachyrrhizine NA 69.1 ± 0.8 NA 80.2 ± 0.2 NA NA NA
12a-hydroxy rotenone 45.7 ± 1.3 60.1 ± 0.9 NA 65.5 ± 0.5 35.1 ± 0.4 15.1 ± 0.1 11.2 ± 0.4
Neoraudiol 35.4 ± 0.6 15.1 ± 0.5 23.4 ± 0.2 17.4 ± 0.6 17.4 ± 0.7 17.5 ± 0.9 17.3 ± 0.1
Rautandiol A NA 20.2 ± 0.6 NA 55.1 ± 0.8 NA 10.2 ± 0.1 17.2 ± 0.3
Gentamicina 12.1 ± 0.2 16.9 ± 0.3 17.5 ± 0.4 16.1 ± 0.2 14.1 ± 0.4 – –
Thioconazoleb – – – – – 20.1 ± 0.2 18.1 ± 0.2
Concentration of reference drugs and isolated compounds is 20 mg/ml. NA= not active.
S. A. = Staphyllococcus aureus, B. S. = Bacillus subtilis, E. C. = Eschericia coli, P. A. = Pseudomonas aueriginosa, S. T. = Salmonella typhii,
C. A. = Candida albicans, A. N. = Aspergillus niger.
a Reference antibacterial drug.
b Reference antifungal drug.
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[C-8a], d 159 [C-7], d 123.5 [C-3], d 122 [C-10], d 119.4 [C-4a], d
119 [C-6], d 107.9 [C-40] and d 104.1[C-30]. A complete assign-
ment of the 1H- and 13C-NMR spectra of 1 was based on the
HMBC, HMQC, COSY and NOESY experiments. The loca-
tion of the carbonyl group was conﬁrmed by the analysis of
its HMBC spectrum. In the HMBC spectrum, there were cor-
relations between the proton signals at d 8.25 [1H, s, H-2], d
8.49 [1H, s, H-5] and the carbon resonance at d 180 ppm. A
comparison of the 1H- NMR signals (dH 8.49, 8.25, 7.94,
7.76 and 7.05 ppm) in rings A, B and C with those reported
for dehydroneotenone (7) in N. mitis are the same (Luc et
al., 1987), except the difference in the substitution pattern in
the aromatic ring D. The substitution pattern in ring D was
further analysed by its 1H-NMR, HMBC and NOESY spec-
troscopic data. An ortho coupled doublets observed in the
1H-NMR at 7.10 (d, J= 8 Hz), 6.41 (1H, dd, J= 8, 2 Hz,);
and a meta coupled doublet at 6.38 (d, J= 2 Hz) were as-
signed to H-50, H-60 and H-20, respectively, on the basis of
NOESY experiment (Table 1). The correlations observed in
HMBC spectrum of 1 indicated that the two –OH groups
are assigned to C-30 and C-40. The dihydroxyl moieties in ring
D were further conﬁrmed by the fragment ion in EIMS at m/z
134 [(33.94%), C8H6O2] (Fig. 1). The carbon signal at
133.1 ppm was assigned to C-20 based on the correlations from
the proton signals located at d 8.25 [1H, s] to the carbon sig-
nals at d 123.5 [C-3] and d 107.9 [C-40], this placed the aromatic
proton at C-20. In addition, the remaining aromatic protons at
positions 50 and 60 were further supported by HMBC correla-
tion between d 7.10 and d 6.41 to d 123.5 [C-3]. On the basis of
the spectral data outlined above, the structure of the com-
pound 1 was deduced as neoraudiol, a new isoﬂavonoid iso-
lated from N. mitis.
3.2. Compound 2 (rautandiol A)
Compound 2 was eluted from column with 1:1 hexane–Et2O as
a grey solid (83 mg, mp 210–211 C, lit mp 210–211 C). The
structure of 2 was conﬁrmed by comparison of its 1D and
2D NMR and EIMS spectroscopic data with those found in
the literature for a pterocarpan, rautandiol A, previously re-
ported from N. mitis (Luc et al., 1987).3.3. Compound 3 (neoduline)
Compound 3 was eluted with hexane/Et2O (3:1, vol/vol) to af-
ford a white powdery solid [95 mg, mp 216–217 C, lit mp
217 C]. Its 1H-, 13C-NMR and EIMS spectral data are consis-
tent to that of neoduline, a pterocarpan, previously reported as
constituents of N. mitis (Luc et al., 1987).
3.4. Compound 4 (neotenone)
Compound 4 was eluted with 9:1 hexane–Et2O as pure green-
ish-white solid [100 mg, mp 157–158 C, lit mp 156 C]. 1H-
and 13C-NMR spectra of the compound were similar to those
reported for neotenone, a ﬂavone previously isolated from N.
mitis (Luc et al., 1987).
3.5. Compound 5 (pachyrrhizine)
Compound 5 was eluted from column with 7:3 hexane–Et2O
and recrystallised from hexane/EtOAc solvent mixture (7:3,
vol/vol) to afford a yellow solid [65 mg, mp 206–207 C, lit
mp 204–205 C]. Compound 5 was identiﬁed as pachyrrhizine,
on the basis of 1H-NMR and GC–MS spectral data, and by
comparison with data reported in the literature (Luc et al.,
1987).
3.6. Compound 6 (12a-hydroxy rotenone)
Compound 6 was eluted from column with 3:2 hexane–Et2O as
a yellow solid (500 mg, mp 86–87 C; lit mp 87–88 C). The
NMR and MS spectral data of 6 established the structure as
12a-hydroxy rotenone, a pterocarpan reported from the tuber-
ous root of N. mitis (Luc et al., 1987).
Compounds 1–6 were assayed for antimicrobial activity
against four bacteria and two fungi by determining the MIC.
The results are shown in Table 2. Compounds 1–6 displayed
varying degree of antimicrobial activities on the pathogenic
strains. Among all the six compounds neoraudiol (1) displayed
highest antimicrobial activity on B. subtilis (MIC 15.10 ±
0.5 mg/ml) and S. typhii (MIC 17.30 ± 0.7 mg/mL). Com-
pound 1 equally demonstrates stronger antifungal activity
against C. albicans (MIC 17.45 ± 0.9 mg/ml) and A. niger
(MIC 17.3 ± 0.1). Rautandiol A (2) exhibits moderate antimi-
Neoraudiol, a new isoﬂavonoid and other antimicrobial constituents 409crobial activity, while other compounds are relatively less ac-
tive. The observed activity of compound 1 can be traced to
the phenolic nature of polyphenols. Previous report had attrib-
uted high activity of phenolic compounds to the presence of
phenolic (–OH) group Aziz et al., 1998). The hydroxyl group
is reactive and forms hydrogen bonds with active sites of en-
zymes. High activity of phenolic compounds on different path-
ogenic strains has been reported (Leticia et al., 2008). The
intrinctly high antimicrobial activity of compound 1 is consis-
tent with earlier report. The lipophilic nature of compound 1
could be attributed for the high antifungal activity, as it allows
it to penetrate more easily through the fungus membrane. The
antibacterial and antifungal activities exhibited by the extracts
and compounds isolated from N. mitis conﬁrmed its use in tra-
ditional medicine for the treatment of syphilis and skin
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